These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25238144)

  • 1. An activatable prodrug for the treatment of metastatic tumors.
    Kim EJ; Bhuniya S; Lee H; Kim HM; Cheong C; Maiti S; Hong KS; Kim JS
    J Am Chem Soc; 2014 Oct; 136(39):13888-94. PubMed ID: 25238144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Boronic acid substituted camptothecin as prodrug of SN-38.
    Wang L; Xie S; Ma L; Chen Y; Lu W
    Eur J Med Chem; 2016 Jun; 116():84-89. PubMed ID: 27060760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen peroxide responsive theranostics for cancer-selective activation of DNA alkylators and real-time fluorescence monitoring in living cells.
    Saxon E; Ali T; Peng X
    Eur J Med Chem; 2024 Oct; 276():116695. PubMed ID: 39047609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
    Leu YL; Chen CS; Wu YJ; Chern JW
    J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy.
    Gao YE; Bai S; Shi X; Hou M; Ma X; Zhang T; Xiao B; Xue P; Kang Y; Xu Z
    Colloids Surf B Biointerfaces; 2018 Oct; 170():488-496. PubMed ID: 29960949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activatable theranostic for targeted cancer therapy and imaging.
    Bhuniya S; Maiti S; Kim EJ; Lee H; Sessler JL; Hong KS; Kim JS
    Angew Chem Int Ed Engl; 2014 Apr; 53(17):4469-74. PubMed ID: 24644015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy.
    Shin WS; Han J; Verwilst P; Kumar R; Kim JH; Kim JS
    Bioconjug Chem; 2016 May; 27(5):1419-26. PubMed ID: 27135737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polymeric prodrug with multivalent components for cancer therapy.
    Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amonafide-based H
    Yao X; Sun W; Yuan Y; Hu J; Fu J; Yin J
    Bioorg Chem; 2024 Sep; 150():107560. PubMed ID: 38878752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
    Hu Y; Zeng F
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
    Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z
    Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation.
    Prijovich ZM; Burnouf PA; Chou HC; Huang PT; Chen KC; Cheng TL; Leu YL; Roffler SR
    Mol Pharm; 2016 Apr; 13(4):1242-50. PubMed ID: 26824303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue.
    Chen KC; Schmuck K; Tietze LF; Roffler SR
    Mol Pharm; 2013 May; 10(5):1773-82. PubMed ID: 23448264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
    Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety.
    Zhu J; Chen J; Song D; Zhang W; Guo J; Cai G; Ren Y; Wan C; Kong L; Yu W
    J Mater Chem B; 2019 Dec; 7(47):7548-7557. PubMed ID: 31720667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
    Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
    Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.
    Alferiev IS; Iyer R; Croucher JL; Adamo RF; Zhang K; Mangino JL; Kolla V; Fishbein I; Brodeur GM; Levy RJ; Chorny M
    Biomaterials; 2015 May; 51():22-29. PubMed ID: 25770994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy.
    Li J; Ke W; Wang L; Huang M; Yin W; Zhang P; Chen Q; Ge Z
    J Control Release; 2016 Mar; 225():64-74. PubMed ID: 26806789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.